PMID- 38463697 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240312 IS - 2573-9832 (Electronic) IS - 2573-9832 (Linking) VI - 6 IP - 3 DP - 2024 Mar TI - Loss of chaperone-mediated autophagy does not alter age-related bone loss in male mice. PG - 73-84 LID - 10.1096/fba.2023-00133 [doi] AB - Chaperone-mediated autophagy (CMA) is a lysosome-dependent degradation pathway that eliminates proteins that are damaged, partially unfolded, or targeted for selective proteome remodeling. CMA contributes to several cellular processes, including stress response and proteostasis. Age-associated increase in cellular stressors and decrease in CMA contribute to pathologies associated with aging in various tissues. CMA contributes to bone homeostasis in young mice. An age-associated reduction in CMA was reported in osteoblast lineage cells; however, whether declining CMA contributes to skeletal aging is unknown. Herein we show that cellular stressors stimulate CMA in UAMS-32 osteoblastic cells. Moreover, the knockdown of an essential component of the CMA pathway, LAMP2A, sensitizes osteoblasts to cell death caused by DNA damage, ER stress, and oxidative stress. As elevations in these stressors are thought to contribute to age-related bone loss, we hypothesized that declining CMA contributes to the age-associated decline in bone formation by sensitizing osteoblast lineage cells to elevated stressors. To test this, we aged male CMA-deficient mice and controls up to 24 months of age and examined age-associated changes in bone mass and architecture. We showed that lack of CMA did not alter age-associated decline in bone mineral density as measured by dual x-ray absorptiometry (DXA). Moreover, microCT analysis performed at 24 months of age showed that vertebral cancellous bone volume, cortical thickness, and porosity of CMA-deficient and control mice were similar. Taken together, these results suggest that reduction of CMA does not contribute to age-related bone loss. CI - (c)2024 The Authors FASEB BioAdvances published by The Federation of American Societies for Experimental Biology. FAU - Hendrixson, James A AU - Hendrixson JA AUID- ORCID: 0009-0004-5175-2357 AD - Department of Physiology and Cell Biology University of Arkansas for Medical Sciences Little Rock Arkansas USA. FAU - James, Alicen AU - James A AUID- ORCID: 0009-0006-4750-4419 AD - Department of Physiology and Cell Biology University of Arkansas for Medical Sciences Little Rock Arkansas USA. FAU - Akel, Nisreen S AU - Akel NS AUID- ORCID: 0009-0007-7326-7020 AD - Department of Physiology and Cell Biology University of Arkansas for Medical Sciences Little Rock Arkansas USA. FAU - Laster, Dominique J AU - Laster DJ AUID- ORCID: 0009-0008-1285-2020 AD - Department of Physiology and Cell Biology University of Arkansas for Medical Sciences Little Rock Arkansas USA. FAU - Crawford, Julie A AU - Crawford JA AUID- ORCID: 0000-0002-8167-8627 AD - Center for Musculoskeletal Disease Research (CMDR) University of Arkansas for Medical Sciences Little Rock Arkansas USA. AD - Division of Endocrinology University of Arkansas for Medical Sciences Little Rock Arkansas USA. FAU - Berryhill, Stuart B AU - Berryhill SB AUID- ORCID: 0009-0003-5119-1062 AD - Center for Musculoskeletal Disease Research (CMDR) University of Arkansas for Medical Sciences Little Rock Arkansas USA. AD - Division of Endocrinology University of Arkansas for Medical Sciences Little Rock Arkansas USA. FAU - Onal, Melda AU - Onal M AUID- ORCID: 0000-0002-5804-495X AD - Department of Physiology and Cell Biology University of Arkansas for Medical Sciences Little Rock Arkansas USA. LA - eng PT - Journal Article DEP - 20240220 PL - United States TA - FASEB Bioadv JT - FASEB bioAdvances JID - 101733210 PMC - PMC10918985 OTO - NOTNLM OT - CMA OT - age-related bone loss OT - aging OT - cellular stress OT - chaperone-mediated autophagy OT - skeletal aging EDAT- 2024/03/11 06:43 MHDA- 2024/03/11 06:44 PMCR- 2024/02/20 CRDT- 2024/03/11 04:26 PHST- 2023/11/10 00:00 [received] PHST- 2024/01/18 00:00 [revised] PHST- 2024/02/06 00:00 [accepted] PHST- 2024/03/11 06:44 [medline] PHST- 2024/03/11 06:43 [pubmed] PHST- 2024/03/11 04:26 [entrez] PHST- 2024/02/20 00:00 [pmc-release] AID - FBA21426 [pii] AID - 10.1096/fba.2023-00133 [doi] PST - epublish SO - FASEB Bioadv. 2024 Feb 20;6(3):73-84. doi: 10.1096/fba.2023-00133. eCollection 2024 Mar.